Navigation Links
Echo Therapeutics to Present at 4th Annual JMP Securities Healthcare Conference
Date:10/1/2009

elating to Echo's ability to develop, market and sell diagnostic and transdermal drug delivery products based on its skin permeation platform technologies, including the Symphony tCGM System and Prelude SkinPrep System, the availability of substantial additional equity or debt capital to support its research, development and product commercialization activities, and the success of its research, development, regulatory approval, marketing and distribution plans and strategies, including those plans and strategies related to its Symphony tCGM System and its Prelude SkinPrep System. These and other risks and uncertainties are identified and described in more detail in Echo's filings with the Securities and Exchange Commission, including, without limitation, its annual report on Form 10-K for the year ended December 31, 2008, its quarterly reports on Form 10-Q, and its current reports on Form 8-K. Echo Therapeutics, Inc. undertakes no obligation to publicly update or revise any forward-looking statements.

www.echotx.com 

    For More Information:
    Patrick T. Mooney, M.D.
    Chairman and Chief Executive Officer
    (508)-530-0329

SOURCE Echo Therapeutics, Inc.


'/>"/>
SOURCE Echo Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
3. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
5. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
8. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
9. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
10. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
11. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...PRNewswire/--AccordingtoMillenniumResearchGroup(MR...lligence,thenearly$3billionUSmarketfortraumafixati...veyearsdespitetherecenteconomicslowdown.MRG,s USMa...ketwillremainhighlydynamicoverthenextfiveyears,wit...slyunderservedsegmentsofthetraumafixationmarket,fu...
(Date:11/25/2009)...wire/--Reportlinker.comannouncesthatanewmarketrese...asalDrugDelivery-USMarketTrends&Analysis http...elivery---US-Market-Trends--Analysis.html ,, T...nsionoftherapeuticapplicationsfromthedeliveryofcon...mictherapeuticdrugs.Thefutureofthetechnologyhinges...
(Date:11/24/2009)...RNewswire-Asia/--ChindexInternational,Inc.,("Chind...viderofWestern,healthcareproductsandservicesintheP...nywillattendthe21stAnnualPiperJaffray,"Unplugged"H...,NewYorkPalaceHotel. , Managementiscurrentlys...009,andholdone-on-onemeetingsthroughouttheday.Aweb...
Breaking Medicine Technology:US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5Chindex International to Present at Piper Jaffray Health Care Conference 2All Eyes on The Medical Home 3A Patient Centered Primary Care Collaborative Convenes National Summit In Washington DC 55867 1All Eyes on The Medical Home 3A Patient Centered Primary Care Collaborative Convenes National Summit In Washington DC 55867 2All Eyes on The Medical Home 3A Patient Centered Primary Care Collaborative Convenes National Summit In Washington DC 55867 3RJR Other Tobacco Companies Go to Court to Evade Regulation by FDA 55862 1RJR Other Tobacco Companies Go to Court to Evade Regulation by FDA 55862 2Sagent Pharmaceuticals Announces Launch of Adenosine Injection USP in 6 mg per 2 mL Single Dose Vials 4930 1Sagent Pharmaceuticals Announces Launch of Adenosine Injection USP in 6 mg per 2 mL Single Dose Vials 4930 2
...GO, June 21, 2007 /PRNewswire-FirstCall/ -- Advanc...positive results from,Trial CL-06, the first of tw...ss the safety and effectiveness of cethromycin, a,...community,acquired pneumonia (CAP). In the study, ...y endpoint of per protocol clinical,cure rate comp...
...NSHIRE, Ill.--(BUSINESS WIRE)--Jun 21, 2007 - BioS...ed comment on the,Women,s Health Initiative (WHI) ...in The New England Journal of Medicine (NEJM).,The...0-59) who,received a standard dose of estrogen the...ication at the end of the study period,compared wi...
Other Medicine Technology:Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia,Clinical Trial 2Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia,Clinical Trial 3Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia,Clinical Trial 4Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia,Clinical Trial 5New Analysis of WHI Data Shows Reduced Levels of Coronary Artery,Calcification, a Predictor of Cardiovascular Events, in Women aged,50-59 taking Estrogen Therapy 2New Analysis of WHI Data Shows Reduced Levels of Coronary Artery,Calcification, a Predictor of Cardiovascular Events, in Women aged,50-59 taking Estrogen Therapy 3New Analysis of WHI Data Shows Reduced Levels of Coronary Artery,Calcification, a Predictor of Cardiovascular Events, in Women aged,50-59 taking Estrogen Therapy 4
(Date:11/25/2009)...nimally-invasive procedures that provide patients ...k of sinusitis, or sinus infection, are being deve...oring Institute. Techniques such as balloon sinup...having to remove any bone or tissue like tradition...throughs in treating sinus symptoms were featured ...
(Date:11/25/2009)...wire/--Therearemanywaysyoucanimprove,yourhealth,an...waysseemstobeconflictingadviceconcerningwhatisgood...o,therealbuzz.comteamhascompiledalistof25health-bo...tible!Doingacombinationof,oursuggestedactivitieswi...eing-sotrythemout. , 1.Reduceyourfatintake.Th...
(Date:11/24/2009)...ercent of radiation oncologists use advanced imagi... (FDG-PET), magnetic resonance imaging (MRI), and ...t delineation (to locate the tumor and other areas...le in the December issue of the Journal of the Am...rg ). , In defining the target, the radiation on...
(Date:11/24/2009)...of Miami School of Medicine compared the outcomes ...nts for nonalcoholic steatohepatitis (NASH) versus...stically significant differences in post-transplan... Study findings are presented in the December issu...by Wiley-Blackwell on behalf of the American Assoc...
(Date:11/24/2009)...ton University School of Medicine (BUSM) and the B... have identified a number of proteins whose activa... normal cells with almost 97 percent accuracy. In ...computational strategy to analyze this data and sp...ular circuits) that are active in cancer and "dorm...
Breaking Medicine News(10 mins):Health News:Atlanta Snoring Institute Uses Breakthrough Techniques to Treat Sinusitis and Sinus Pain 2Health News:Atlanta Snoring Institute Uses Breakthrough Techniques to Treat Sinusitis and Sinus Pain 3Health News:Atlanta Snoring Institute Uses Breakthrough Techniques to Treat Sinusitis and Sinus Pain 4Health News:realbuzz.com - Top 25 Ways to Improve Your Health & get a Better Sex Life! 2Health News:New data emerges on liver transplant survival rates 2Health News:New data emerges on liver transplant survival rates 3Health News:Researchers identify proteins in lung cancer cells that may provide potential drug targets 2
...covered that suffering from infection increases th...hich is a dangerous condition in which blood clots... That infection can cause an increase in the risk ... that infection can also cause DVT. Research...
...h HIV/AIDS have opposed a patent application filed...ir, a fixed dose combination AIDS drug on the grou... // Represented by the Lawyers' Collective ...tion to a patent application filed at the Kolkata ...
...ical Center and John Hopkins University School of ...aling pathway that plays a vital role in the embry...o injury lead to the development of liver cancer. ...rgeted treatment of liver cancer, which happens to...
... propagate a new method of sex education for young...vice president with the China Family Planning Asso... arrived earlier in recent years, but sex educatio...ar. Education on sex and reproductive health ...
... among city kids in Britain, increasing their susc...archers, only 37% of the urban kids really walk to...suburban areas. Nearly 47% of the kids spend almos...he above 40 age group. In Britain, more than ...
...ggests, that a pain killing medication helps by ha... common form of breast cancer. The name of the pai...iments on breast cancer cells, scientists found th...e most common breast cancer in postmenopausal wome...
Other Medicine News:Health News:HIV Patients Opposes Patenting Of AIDS Drug 2Health News:Unchecked Cellular Repair Pathway Causes Liver Cancer 2Health News:Pain-killer Drug Can Help Fight Breast Cancer 2
Cushing Periosteal Elevators
Adson Periosteal Elevators
Lederer Periosteal Elevators
Molt 9 Periosteal Elevators
Medicine Products: